[Construction and immunogenicity of a genetic engineered strain expressing nontoxic ST1-LT(B)-alpha-beta fusion protein against diarrhea of piglet].

Abstract	We constructed a recombinant strain BL21 (DE3) (pETST3LTBalphabeta) including ST1-LT(B)-alpha-beta fusion gene via molecular technology. The SDS-PAGE and Western blotting indicated that the ST1-LT(B)-alpha-beta fusion protein was highly expressed in Escherichia coli and the molecular weight of the fusion protein was about 110 kD. The recombinant strain was induced in different concentrations of lactose and different aeration rate. The optimal culture conditions in 20 L fermentor were 1% inoculation (V/V), initial aeration 5 L/min, 0.03 mol/L lactose addition 3 hours after inoculation, and increased the aeration to 12.5 L/min for the following 6 hours. The fusion protein was about 38.53% of total cellular protein. It was nontoxic, immunogenic and protective against enterotoxigenic E. coli and Clostridium perfringens infection. The constructed recombinant strain BL21 (DE3) (pETST3LTBalphabeta) could serve as a candidate vaccine strain against diarrhea of piglet.
Authors	Jie Song, Mingming Qian, Jianing Bai, Baohua Zhao
Journal	Sheng wu gong cheng xue bao = Chinese journal of biotechnology (Sheng Wu Gong Cheng Xue Bao) Vol. 24 Issue 8 Pg. 1340-7 (Aug 2008) ISSN: 1000-3061 [Print] China
PMID	18998533 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Bacterial Toxins CPB protein, Clostridium perfringens Calcium-Binding Proteins Enterotoxins Escherichia coli Proteins Recombinant Fusion Proteins Vaccines, Synthetic heat stable toxin (E coli) heat-labile enterotoxin, E coli Type C Phospholipases alpha toxin, Clostridium perfringens
Topics	Animals Bacterial Toxins (biosynthesis, genetics) Calcium-Binding Proteins (biosynthesis, genetics) Clostridium perfringens (genetics) Dysentery (prevention & control, veterinary) Enterotoxins (biosynthesis, genetics) Escherichia coli (genetics, immunology) Escherichia coli Proteins (biosynthesis, genetics) Recombinant Fusion Proteins (biosynthesis, genetics, immunology) Swine Transformation, Bacterial (genetics) Type C Phospholipases (biosynthesis, genetics) Vaccines, Synthetic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!